DCA seizes overpriced drugs in Kapra, medicines with false claims in Secunderabad, Kondapur
Stringent actions are being initiated against the violators as per the Drugs and Cosmetics Act and Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
By Newsmeter Network Published on 22 Nov 2024 10:53 AM GMT
DCA raids in Telangana
Hyderabad: The Drugs Control Administration (DCA), Telangana, conducted raids on Thursday, uncovering illegal drug sales, overpriced medicines and misleading advertisements across multiple locations.
Stringent actions are being initiated against the violators as per the Drugs and Cosmetics Act and Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Raids on clinics operated by quacks
DCA officials raided clinics run by unqualified individuals posing as rural medical practitioners (RMPs) in Bijwar Village (Narayanpet District), Bodu Village (Bhadradri-Kothagudem District) and Bachupally Village (Medchal-Malkajgiri District).
Details of the accused and the seized drugs include:
• D Narsimha (Bijwar Village, Narayanpet District): 41 varieties of medicines.
• Masipaka Anvesh (Bodu Village, Bhadradri-Kothagudem District): 29 varieties, including 12 physician’s samples.
• Gantha Dharmaraju (Bachupally Village, Medchal-Malkajgiri District): 13 varieties of medicines.
The seized medicines included antibiotics like Cefixime and Amoxicillin, steroids such as Hydrocortisone and Norethisterone and other drugs including analgesics and anti-ulcer medicines. The estimated value of the seized stock is Rs 83,000.
The inspections were carried out by drugs inspectors S Vinay (Narayanpet), Ch. Sampath Kumar (Bhadradri-Kothagudem), M Sreebindu (Bachupally), M Hemalatha (Gandimaisamma) and S Vishwanth Reddy (Nagarkurnool). Samples were collected for further analysis and legal action will follow.
Seizure of overpriced medicine in Kapra
In a separate operation in Kapra, Medchal-Malkajgiri District, officials seized overpriced Izol 100 Capsules (Itraconazole Capsules 100 mg) sold at Rs 79.99 for four capsules, exceeding the maximum permissible price of Rs 74.68.
The inspection was led by drugs inspector T Shiva Teja. Further investigations are underway to identify those responsible for the pricing violations.
Misleading drug advertisements detected
During a special drive, DCA officials identified several drugs making false claims in violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Detected products include:
1. Triphala Powder (Ayurvedic Medicine): Claimed to treat cardiovascular disorders and high blood pressure.
• Manufacturer: Manphar Ayurvedic Drugs, Vijayawada.
• Location: Jangaon.
2. ED Phenicol (Allopathic Medicine): Claimed to treat and prevent eye infections.
• Manufacturer: Eamon Drugs Pvt. Ltd., Madhya Pradesh.
• Location: Jeedimetla, Medchal-Malkajgiri District.
3. Tulasi Leaf Churnam (Ayurvedic Medicine): Claimed to treat fever.
• Manufacturer: Akheera Drugs Cosmetics, Balanagar.
• Location: Begumpet, Secunderabad.
4. KAPIVA BP Care Juice (Ayurvedic Medicine): Claimed to treat blood pressure.
• Manufacturer: Veloce Herbals Pvt. Ltd., Madhya Pradesh.
• Location: Kondapur, Ranga Reddy District.
5. Madhuriktha Powder (Ayurvedic Medicine): Claimed to treat diabetes.
• Manufacturer: Samraksha Ayurvedic Pharmacy, Kukatpally.
• Location: Jagtial.
Officials emphasised the risks of such misleading claims.
The inspections were carried out by drugs inspectors V Upender (Jagtial), A Shylaja Rani (Sherilingampalli), M Surendranath (Begumpet), A Saritha (Jeedimetla) and A Balakrishna (Jangaon). Legal action will be initiated against the manufacturers and distributors of these products.
Public awareness and reporting
The DCA has urged the public to report any suspicious activities related to drug manufacturing, sales, or misleading claims through their toll-free helpline: 1800-599-6969, operational on all working days from 10:30 am to 5 pm.
VB Kamalasan Reddy, IPS, director general of the Drugs Control Administration, reiterated the department’s commitment to public health and safety, stating: “We will continue our efforts to crack down on illegal practices and ensure that the provisions of the Drugs and Cosmetics Act are strictly enforced.”
The DCA also reminded wholesalers and dealers to verify drug licenses before supplying medicines, warning of stringent penalties for non-compliance.
